Well any transaction for the company equity would require approval by the Company creditors and the Court...not to mention the SEC disclosure requirements that BioAmber Inc. has as an SEC registrant.
There has been no deal or transaction involving the company equity. The fact that they also say none is anticipated means no meanginful offers have been received notwithstanding the Crane group offer that was rejected by PwC and the secured creditors.
Market Data 
Markets 
AI
